The combination drug valsartan/sacubitril (LCZ696) reduced pulse wave velocity and aortic systolic blood pressure in patients with stable heart failure with reduced ejection fraction

Kobalava Z. , Villevalde S. , Tyukhmenev E. , Lukina O.O. , Babaeva L. , Zharikova E.

Европейский журнал сердечной недостаточности

Elsevier Science Publishing Company, Inc.

Английский

335-335

Опубликовано

18

2016